Literature DB >> 24566009

Hepatitis C virus (HCV)-specific memory B-cell responses in transiently and chronically infected HIV positive individuals.

Sven Reiche1, Claudia Nestler1, Michael Sieg1, Katharina Schulz1, Christiane Cordes2, Ivanka Krznaric3, Christian Jassoy4.   

Abstract

BACKGROUND: Antibody responses to hepatitis C virus (HCV) occur delayed and overly decline after viral clearance indicating that the B-cell response to HCV is abnormal. Virus-specific memory B-cells have recently been found in infected individuals, but the viral exposure requirements for the generation of these cells is unknown.
OBJECTIVES: The primary goal of this study was to quantify and compare the HCV-specific memory B-cell response between chronic and resolved HCV-infected individuals. A secondary goal was to examine if HIV-specific memory B-cell responses are maintained during HCV co-infection. STUDY
DESIGN: HCV core protein- and HIV-specific memory B-cell responses were examined in HIV/HCV-infected individuals treated 4-30 weeks after HCV diagnosis. Memory B-cell frequencies were compared between chronically and transiently infected individuals.
RESULTS: Chronically infected individuals had vigorous HCV-specific memory B-cell responses and antibodies, whereas subjects with transient viremia showed low or undetectable virus-specific B-cell responses. In addition, chronically HIV/HCV-infected subjects had robust HIV-specific memory B-cell responses.
CONCLUSIONS: Whereas chronic HCV infection induces virus-specific antibodies and memory B-cells, transient infection in individuals with sustained viral response to therapy does not stimulate a durable HCV-specific B-cell response indicating that the formation of long-lived virus-specific B-cells is suppressed in the early phase of infection. This may contribute to the inability to spontaneously clear HCV infection.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HIV; Hepatitis C virus; Memory B-lymphocytes; Pathogenesis

Mesh:

Substances:

Year:  2014        PMID: 24566009     DOI: 10.1016/j.jcv.2014.01.023

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  4 in total

1.  High Inter-Individual Diversity of Point Mutations, Insertions, and Deletions in Human Influenza Virus Nucleoprotein-Specific Memory B Cells.

Authors:  Sven Reiche; Yamen Dwai; Bianca M Bussmann; Susanne Horn; Michael Sieg; Christian Jassoy
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

2.  Stimulation of B Cell Immunity in Flavivirus-Naive Individuals by the Tetravalent Live Attenuated Dengue Vaccine TV003.

Authors:  Huy A Tu; Usha K Nivarthi; Nancy R Graham; Philip Eisenhauer; Matthew J Delacruz; Kristen K Pierce; Stephen S Whitehead; Jonathan E Boyson; Jason W Botten; Beth D Kirkpatrick; Anna P Durbin; Aravinda M deSilva; Sean A Diehl
Journal:  Cell Rep Med       Date:  2020-12-22

3.  Comparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5' Terminus of Hepatitis C Virus RNA.

Authors:  Irina Sominskaya; Juris Jansons; Anastasija Dovbenko; Natalia Petrakova; Ilva Lieknina; Marija Mihailova; Oleg Latyshev; Olesja Eliseeva; Irina Stahovska; Inara Akopjana; Ivars Petrovskis; Maria Isaguliants
Journal:  J Immunol Res       Date:  2015-11-02       Impact factor: 4.818

4.  Evaluation of immunological indices in HIV-infected patients with chronic hepatitis C in Kazakhstan.

Authors:  Nazgul Sarsekeyeva; Bakhyt Kosherova
Journal:  Int J Gen Med       Date:  2016-05-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.